药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Codeine-N-oxide
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Dexverapamil.
Codeine-N-oxide
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Dexverapamil.
Codeine-N-oxide
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Dexverapamil.
Codeine-N-oxide
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Dexverapamil.
Codeine-N-oxide
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Dexverapamil.
Codeine-N-oxide
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Dexverapamil.
Codeine-N-oxide
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Dexverapamil.
Codeine-N-oxide
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Dexverapamil.
Codeine-N-oxide
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Dexverapamil.
Codeine-N-oxide
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dexverapamil.
Codeine-N-oxide
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Dexverapamil.
Codeine-N-oxide
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dexverapamil.
Codeine-N-oxide
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Dexverapamil.
Codeine-N-oxide
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Dexverapamil.
Codeine-N-oxide
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Dexverapamil.
Codeine-N-oxide
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Dexverapamil.
Codeine-N-oxide
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Dexverapamil.
Codeine-N-oxide
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Dexverapamil.
Codeine-N-oxide
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Dexverapamil.
Codeine-N-oxide
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dexverapamil.